Soeren Mattke

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Nature reviews. Neurology

Nature aging

Alzheimer's & dementia : the journal of the Alzheimer's Association

Journal of health services research & policy

This page only lists publications with an associated author ORCID identifier.

Publications

Suzanne E Schindler, Douglas Galasko, Ana C Pereira, Gil D Rabinovici, Stephen Salloway, Marc Suarez-Calvet, Ara S Khachaturian, Michelle M Mielke, Chi Udeh-Momoh, Joan Weiss, Richard Batrla, Sasha Bozeat, John R Dwyer, Drew Holzapfel, Daryl Rhys Jones, James F Murray, Katherine A Partrick, Emily Scholler, George Vradenburg, Dylan Young, Alicia Algeciras-Schimnich, Jiri Aubrecht, Joel B Braunstein, James Hendrix, Yan Helen Hu, Soeren Mattke, Mark Monane, David Reilly, Elizabeth Somers, Charlotte E Teunissen, Eli Shobin, Hugo Vanderstichele, Michael W Weiner, David Wilson, Oskar Hansson
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease. Nature reviews. Neurology 20 (7) (2024)
Suzanne E Schindler, Douglas Galasko, Ana C Pereira, Gil D Rabinovici, Stephen Salloway, Marc Suarez-Calvet, Ara S Khachaturian, Michelle M Mielke, Chi Udeh-Momoh, Joan Weiss, Richard Batrla, Sasha Bozeat, John R Dwyer, Drew Holzapfel, Daryl Rhys Jones, James F Murray, Katherine A Partrick, Emily Scholler, George Vradenburg, Dylan Young, Alicia Algeciras-Schimnich, Jiri Aubrecht, Joel B Braunstein, James Hendrix, Yan Helen Hu, Soeren Mattke, Mark Monane, David Reilly, Elizabeth Somers, Charlotte E Teunissen, Eli Shobin, Hugo Vanderstichele, Michael W Weiner, David Wilson, Oskar Hansson
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease. Nature reviews. Neurology 20 (7) (2024)
Suzanne E Schindler, Douglas Galasko, Ana C Pereira, Gil D Rabinovici, Stephen Salloway, Marc Suarez-Calvet, Ara S Khachaturian, Michelle M Mielke, Chi Udeh-Momoh, Joan Weiss, Richard Batrla, Sasha Bozeat, John R Dwyer, Drew Holzapfel, Daryl Rhys Jones, James F Murray, Katherine A Partrick, Emily Scholler, George Vradenburg, Dylan Young, Alicia Algeciras-Schimnich, Jiri Aubrecht, Joel B Braunstein, James Hendrix, Yan Helen Hu, Soeren Mattke, Mark Monane, David Reilly, Elizabeth Somers, Charlotte E Teunissen, Eli Shobin, Hugo Vanderstichele, Michael W Weiner, David Wilson, Oskar Hansson
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease. Nature reviews. Neurology 20 (7) (2024)
Suzanne E Schindler, Douglas Galasko, Ana C Pereira, Gil D Rabinovici, Stephen Salloway, Marc Suarez-Calvet, Ara S Khachaturian, Michelle M Mielke, Chi Udeh-Momoh, Joan Weiss, Richard Batrla, Sasha Bozeat, John R Dwyer, Drew Holzapfel, Daryl Rhys Jones, James F Murray, Katherine A Partrick, Emily Scholler, George Vradenburg, Dylan Young, Alicia Algeciras-Schimnich, Jiri Aubrecht, Joel B Braunstein, James Hendrix, Yan Helen Hu, Soeren Mattke, Mark Monane, David Reilly, Elizabeth Somers, Charlotte E Teunissen, Eli Shobin, Hugo Vanderstichele, Michael W Weiner, David Wilson, Oskar Hansson
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease. Nature reviews. Neurology (2024)
Suzanne E Schindler, Douglas Galasko, Ana C Pereira, Gil D Rabinovici, Stephen Salloway, Marc Suarez-Calvet, Ara S Khachaturian, Michelle M Mielke, Chi Udeh-Momoh, Joan Weiss, Richard Batrla, Sasha Bozeat, John R Dwyer, Drew Holzapfel, Daryl Rhys Jones, James F Murray, Katherine A Partrick, Emily Scholler, George Vradenburg, Dylan Young, Alicia Algeciras-Schimnich, Jiri Aubrecht, Joel B Braunstein, James Hendrix, Yan Helen Hu, Soeren Mattke, Mark Monane, David Reilly, Elizabeth Somers, Charlotte E Teunissen, Eli Shobin, Hugo Vanderstichele, Michael W Weiner, David Wilson, Oskar Hansson
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease. Nature reviews. Neurology 20 (7) (2024)
Soeren Mattke, Wei Kok Loh, Kah-Hung Yuen, Joanne Yoong
Preparedness of China's health care system to provide access to a disease-modifying Alzheimer's treatment. Alzheimer's & dementia : the journal of the Alzheimer's Association (2023)
Soeren Mattke, Yu Tang, Mark Hanson
Expected wait times for access to a disease-modifying Alzheimer's treatment in England: A modelling study. Journal of health services research & policy (2023)
Harald Hampel, Rhoda Au, Soeren Mattke, Wiesje Maria van der Flier, Paul Aisen, Liana Apostolova, Christopher Chen, Min Cho, Susan De Santi, Peng Gao, Atsushi Iwata, Ricky Kurzman, Andrew J Saykin, Stefan Teipel, Bruno Vellas, Andrea Vergallo, Huali Wang, Jeffrey Cummings
Designing the next-generation clinical care pathway for Alzheimer's disease. Nature aging 2 (8) (2022)
Harald Hampel, Rhoda Au, Soeren Mattke, Wiesje Maria van der Flier, Paul Aisen, Liana Apostolova, Christopher Chen, Min Cho, Susan De Santi, Peng Gao, Atsushi Iwata, Ricky Kurzman, Andrew J Saykin, Stefan Teipel, Bruno Vellas, Andrea Vergallo, Huali Wang, Jeffrey Cummings
Designing the next-generation clinical care pathway for Alzheimer's disease. Nature aging 2 (8) (2022)
Harald Hampel, Rhoda Au, Soeren Mattke, Wiesje Maria van der Flier, Paul Aisen, Liana Apostolova, Christopher Chen, Min Cho, Susan De Santi, Peng Gao, Atsushi Iwata, Ricky Kurzman, Andrew J Saykin, Stefan Teipel, Bruno Vellas, Andrea Vergallo, Huali Wang, Jeffrey Cummings
Designing the next-generation clinical care pathway for Alzheimer's disease. Nature aging 2 (8) (2022)
Soeren Mattke, Otelo Corrêa Dos Santos Filho, Mark Hanson, Elaine Fernandes Mateus, João Paulo Reis Neto, Leonardo Cruz de Souza, Rodrigo Rizek Schultz, Roney Pereira Pinto
Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer's disease treatment. Alzheimer's & dementia : the journal of the Alzheimer's Association (2022)
Harald Hampel, Rhoda Au, Soeren Mattke, Wiesje Maria van der Flier, Paul Aisen, Liana Apostolova, Christopher Chen, Min Cho, Susan De Santi, Peng Gao, Atsushi Iwata, Ricky Kurzman, Andrew J Saykin, Stefan Teipel, Bruno Vellas, Andrea Vergallo, Huali Wang, Jeffrey Cummings
Designing the next-generation clinical care pathway for Alzheimer's disease. Nature aging 2 (8) (2022)
Harald Hampel, Rhoda Au, Soeren Mattke, Wiesje Maria van der Flier, Paul Aisen, Liana Apostolova, Christopher Chen, Min Cho, Susan De Santi, Peng Gao, Atsushi Iwata, Ricky Kurzman, Andrew J Saykin, Stefan Teipel, Bruno Vellas, Andrea Vergallo, Huali Wang, Jeffrey Cummings
Designing the next-generation clinical care pathway for Alzheimer's disease. Nature aging 2 (8) (2022)
Jenny Lam, Soeren Mattke
Memory care approaches to better leverage capacity of dementia specialists: a narrative synthesis. Neurodegenerative disease management 11 (3) (2021)
Michael A McCrea, Steven C Cramer, David O Okonkwo, Soeren Mattke, Susan Paadre, Damien Bates, Bijan Nejadnik, Joseph T Giacino
Determining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury. Expert review of neurotherapeutics 21 (9) (2021)
Soeren Mattke, Steven C Cramer, Mo Wang, Janet Prvu Bettger, Kevin M Cockroft, Wuwei Feng, Michael Jaffee, Tolu O Oyesanya, Ava M Puccio, Nancy Temkin, Carolee Winstein, Steven L Wolf, Michael R Yochelson
Estimating minimal clinically important differences for two scales in patients with chronic traumatic brain injury. Current medical research and opinion 36 (12) (2020)

Soeren Mattke.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Soeren Mattke